ClinicalTrials.govpublic full text
Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET
non-small cell lung cancer, mirati, mgcd265, met, nsclc, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 908272
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.